Daniel Schneeberger: Stock Portfolio, Performance and Latest Trades
ADAR1 Capital Management
13F portfolio value
$2.2B
277 holdings at Q2 2026
Get an email when Daniel Schneeberger files a new 13F report
Free, no account needed. Unsubscribe with one click.
Daniel Schneeberger's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
Abivax Sa-AdrABVX | 11.3% | $41.47 | +115% | $89.05 | Added +29% |
| 5.54% | $32.09 | +336% | $139.91 | Reduced −3.3% | |
| 5.25% | $11.61 | +195% | $34.21 | Reduced −3.9% | |
| 4.53% | $669.81 | +15.5% | $773.93 | Added +70% | |
Immunovant Inc.IMVT | 4.22% | $19.79 | +52.9% | $30.26 | Reduced −13% |
Zai Lab Ltd-AdrZLAB | 3.01% | $21.10 | +17.6% | $24.81 | Added +136% |
| 2.25% | $30.11 | +6.0% | $31.92 | Added +816% | |
Crinetics Pharmaceuticals In22663K107 | 2.15% | $38.17 | — | — | Added +7.3% |
| 1.86% | $106.11 | +11.7% | $118.48 | No change | |
| 1.83% | $57.45 | +7.9% | $62.01 | Reduced −28% | |
Septerna Inc.SEPN | 1.48% | $8.10 | +355% | $36.90 | Reduced −14% |
| 1.46% | $5.43 | +22.0% | $6.63 | Reduced −17% | |
| 1.35% | $2.92 | −2.8% | $2.84 | New | |
| 1.24% | $19.80 | −5.7% | $18.67 | Reduced −45% | |
| 1.19% | $35.66 | +124% | $79.90 | Reduced −16% | |
| 1.18% | $7.97 | +39.6% | $11.12 | Reduced −10% | |
| 1.17% | $316.12 | −16.6% | $263.55 | Added +4850% | |
Insmed Inc.INSM | 1.15% | $126.15 | −20.3% | $100.48 | Added +546% |
| 1.08% | $27.63 | +6.0% | $29.30 | Added +45% | |
| 1.05% | $32.11 | −13.6% | $27.73 | Added +152% | |
| 0.97% | $2.55 | +73.8% | $4.43 | Added +2.0% | |
| 0.95% | $52.39 | +60.3% | $83.98 | Reduced −18% | |
| 0.94% | $1.95 | +19.9% | $2.34 | Added +63% | |
| 0.92% | $29.32 | +38.6% | $40.63 | Added +18% | |
| 0.92% | $13.42 | −9.8% | $12.10 | Added +2518% | |
| 0.80% | $54.95 | −25.8% | $40.80 | Added +51% | |
| 0.79% | $71.04 | −6.1% | $66.69 | Reduced −7.5% | |
| 0.77% | $48.72 | +286% | $188.12 | Reduced −35% | |
| 0.75% | $53.03 | +14.3% | $60.61 | Reduced −13% | |
| 0.72% | $7.63 | +12.8% | $8.61 | Reduced −1.7% | |
| 0.71% | $88.47 | +1.3% | $89.64 | Reduced −36% | |
| 0.70% | $2.13 | −10.2% | $1.91 | Added +12% | |
Uniqure NVQURE | 0.70% | $45.45 | −50.4% | $22.54 | Added +326% |
Rallybio Corp.RLYB | 0.70% | $12.73 | +33.5% | $16.99 | Added +4411% |
| 0.65% | $639.14 | +15.7% | $739.57 | Added +83% | |
| 0.64% | $4.71 | −29.5% | $3.32 | Added +66% | |
| 0.63% | $16.97 | −9.7% | $15.32 | Reduced −23% | |
| 0.62% | $41.32 | +4.8% | $43.30 | Added +3.7% | |
| 0.62% | $48.78 | +33.3% | $65.04 | Added +87% | |
| 0.62% | $20.30 | −10.3% | $18.21 | Added +179% | |
| 0.59% | $2.31 | +7.1% | $2.47 | Reduced −1.3% | |
| 0.59% | $15.13 | +26.4% | $19.13 | New | |
| 0.58% | $91.58 | −0.1% | $91.47 | No change | |
| 0.57% | $1.44 | +0.3% | $1.44 | Added +0.9% | |
| 0.55% | $11.56 | +34.2% | $15.51 | Added +763% | |
Climb Bio Inc.CLYM | 0.50% | $4.65 | +133% | $10.86 | Added +38% |
| 0.50% | $10.31 | +1.8% | $10.50 | No change | |
Zura Bio Ltd.ZURA | 0.49% | $4.31 | −4.1% | $4.13 | Added +179% |
| 0.48% | $3.05 | −24.5% | $2.30 | Reduced −8.1% | |
| 0.48% | $27.04 | −4.3% | $25.88 | Added +577% | |
| 0.47% | $37.31 | −3.1% | $36.16 | Reduced −27% | |
| 0.44% | $18.66 | +110% | $39.25 | Added +3.5% | |
| 0.44% | $20.13 | +83.7% | $36.98 | Reduced −36% | |
| 0.42% | $23.13 | +10.7% | $25.61 | New | |
| 0.42% | $4.96 | +449% | $27.20 | Reduced −51% | |
| 0.41% | $20.89 | −54.3% | $9.55 | Reduced −48% | |
Savara Inc.SVRA | 0.41% | $3.23 | +49.5% | $4.83 | Reduced −4.2% |
Vaxcyte Inc.PCVX | 0.40% | $36.99 | +75.8% | $65.02 | Reduced −44% |
CG Oncology Inc.CGON | 0.40% | $29.61 | +114% | $63.26 | Reduced −36% |
| 0.38% | $26.11 | −14.3% | $22.38 | Added +93% | |
| 0.36% | $233.60 | −4.7% | $222.69 | New | |
| 0.36% | $10.10 | +4.0% | $10.50 | New | |
| 0.36% | $16.76 | +32.5% | $22.21 | Added +459% | |
Biohaven Ltd.BHVN | 0.35% | $11.71 | +1.8% | $11.93 | Added +1020% |
| 0.35% | $3.80 | −5.8% | $3.58 | Added +1.2% | |
Freenome Inc.FRNM | 0.35% | $10.51 | +50.4% | $15.81 | Added +35% |
| 0.34% | $3.43 | +30.1% | $4.46 | Reduced −3.5% | |
| 0.34% | $5.35 | −40.0% | $3.21 | Added +6.7% | |
Damora Therapeutics Inc.36322Q206 | 0.34% | $25.90 | — | — | Added +0.4% |
| 0.34% | $5.88 | +122% | $13.04 | Reduced −59% | |
Leonabio Inc.LONA | 0.34% | $5.67 | +1.4% | $5.75 | Added +6.8% |
Korro Bio Inc.KRRO | 0.33% | $11.01 | −3.9% | $10.58 | No change |
| 0.33% | $10.43 | −1.2% | $10.30 | New | |
Inflarx NVIFRX | 0.32% | $1.83 | −16.4% | $1.53 | Added +1795% |
| 0.32% | $14.52 | +19.9% | $17.41 | New | |
| 0.30% | $21.73 | −14.9% | $18.50 | Added +41% | |
| 0.30% | $1.24 | −19.5% | $1.00 | Added +113% | |
| 0.29% | $4.01 | −13.5% | $3.47 | Added +944% | |
| 0.29% | $154.21 | +112% | $327.30 | Reduced −18% | |
| 0.29% | $3.59 | +16.4% | $4.18 | Reduced −60% | |
Pfizer Inc.PFE | 0.29% | $26.30 | +5.8% | $27.82 | Added +226% |
| 0.28% | $57.72 | −15.1% | $48.99 | No change | |
| 0.27% | $25.43 | +54.2% | $39.23 | Added +58% | |
Alector Inc.ALEC | 0.27% | $1.93 | +4.6% | $2.02 | Added +175% |
| 0.27% | $4.12 | −9.1% | $3.75 | Added +1099% | |
| 0.27% | $30.63 | +98.3% | $60.74 | Reduced −0.7% | |
| 0.26% | $2.01 | +4.7% | $2.10 | Reduced −2.1% | |
| 0.26% | $10.08 | +8.2% | $10.91 | No change | |
| 0.26% | $82.39 | −11.0% | $73.33 | Added +249% | |
| 0.25% | $5.36 | +92.6% | $10.32 | Added +0.5% | |
| 0.24% | $10.04 | — | — | New | |
| 0.24% | $9.97 | +1.8% | $10.15 | No change | |
Bridgebio Pharma Inc.Bond10806XAJ1 | 0.23% | — | — | — | No change |
Bridgebio Pharma Inc.Bond10806XAD4 | 0.23% | — | — | — | No change |
| 0.23% | $218.64 | −0.5% | $217.46 | Reduced −16% | |
| 0.23% | $2.50 | +3.2% | $2.58 | New | |
| 0.23% | $28.86 | −10.9% | $25.72 | New | |
| 0.23% | $9.82 | −53.6% | $4.56 | Reduced −56% | |
Ataibeckley Inc.04650F101 | 0.23% | $3.54 | — | — | No change |
| 0.23% | $4.06 | −4.4% | $3.88 | Added +489% | |
| 0.22% | $10.63 | −0.7% | $10.56 | New | |
| 0.22% | $1.21 | −36.4% | $0.769 | New | |
Pepgen Inc.PEPG | 0.22% | $1.74 | +37.1% | $2.38 | Added +61% |
| 0.21% | $11.74 | +12.3% | $13.18 | Added +0.8% | |
Isoray Inc.CATX | 0.19% | $3.95 | −31.3% | $2.71 | Added +61% |
Apogee Therapeutics Inc.03770N101 | 0.19% | $132.73 | — | — | New |
| 0.19% | $18.99 | +12.0% | $21.26 | No change | |
| 0.19% | $11.24 | −53.1% | $5.27 | Added +27% | |
Biogen Inc.BIIB | 0.18% | $167.13 | +30.7% | $218.43 | Added +63% |
Xencor Inc.XNCR | 0.18% | $13.03 | +88.0% | $24.50 | Added +148% |
| 0.17% | $7.13 | +33.5% | $9.52 | Added +97% | |
| 0.17% | $82.75 | −45.0% | $45.54 | Added +16% | |
Pharvaris NVPHVS | 0.17% | $22.00 | +41.4% | $31.12 | No change |
| 0.17% | $1.73 | +2.9% | $1.78 | New | |
| 0.17% | $1.91 | −24.1% | $1.45 | Reduced −24% | |
| 0.17% | $5.55 | −52.3% | $2.65 | No change | |
Bridgebio Pharma Inc.Bond10806XAB8 | 0.16% | — | — | — | No change |
| 0.16% | $6.80 | +31.2% | $8.92 | New | |
| 0.16% | $323.69 | +8.2% | $350.13 | No change | |
Invivyd Inc.IVVD | 0.16% | $1.10 | −36.4% | $0.70 | Reduced −0.4% |
| 0.15% | $11.32 | — | — | Added +3.3% | |
| 0.15% | $3.53 | −28.9% | $2.51 | Added +351% | |
| 0.15% | $4.64 | −31.6% | $3.17 | No change | |
| 0.13% | $9.75 | +54.3% | $15.04 | No change | |
| 0.13% | $56.35 | −2.6% | $54.89 | Added +169% | |
| 0.13% | $20.77 | −17.3% | $17.17 | Added +109% | |
| 0.12% | $12.66 | −8.0% | $11.64 | Added +154% | |
| 0.12% | $1.51 | +60.3% | $2.42 | Reduced −34% | |
Sanofi-AdrSNY | 0.11% | $47.03 | −14.5% | $40.23 | Reduced −82% |
| 0.11% | $11.19 | −3.2% | $10.83 | Reduced −43% | |
| 0.11% | $14.23 | +58.6% | $22.57 | Added +54% | |
| 0.11% | $462.31 | −10.1% | $415.41 | Added +230% | |
| 0.11% | $1.88 | −42.1% | $1.09 | Added +46% | |
Omniab Inc.OABI | 0.11% | $2.08 | +124% | $4.66 | Added +34% |
| 0.10% | $26.64 | −69.9% | $8.01 | No change | |
| 0.10% | $79.08 | −34.2% | $52.00 | Reduced −11% | |
| 0.09% | $12.33 | +527% | $77.28 | No change | |
Vyne Therapeutics Inc.92941V308 | 0.09% | $0.63 | — | — | Added +177% |
| 0.09% | $803.99 | +15.7% | $930.25 | Added +108% | |
| 0.08% | $1.45 | +21.0% | $1.76 | No change | |
| 0.08% | $9.38 | +8.8% | $10.21 | Added +33% | |
| 0.08% | $31.56 | −29.2% | $22.33 | New | |
| 0.08% | $9.53 | −22.9% | $7.35 | No change | |
| 0.08% | $25.79 | +205% | $78.75 | No change | |
| 0.08% | $2.61 | −66.2% | $0.881 | Reduced −5.7% | |
| 0.07% | $10.25 | +2.1% | $10.46 | No change | |
| 0.07% | $7.84 | −66.5% | $2.63 | Added +0.7% | |
| 0.07% | $18.79 | +70.3% | $32.01 | New | |
Evommune Inc.EVMN | 0.06% | $18.78 | −65.9% | $6.41 | Reduced −43% |
| 0.06% | $3.26 | −12.7% | $2.85 | Added +579% | |
| 0.06% | $7.85 | +5.6% | $8.29 | Added +27% | |
| 0.06% | $44.57 | −5.5% | $42.14 | Reduced −6.1% | |
| 0.06% | $47.38 | −19.4% | $38.18 | Reduced −18% | |
Avantor Inc.AVTR | 0.06% | $10.87 | +41.6% | $15.39 | Added +63% |
| 0.06% | $1.55 | −14.2% | $1.33 | New | |
| 0.06% | $14.91 | −38.6% | $9.15 | Reduced −2.6% | |
Arrowhead Pharmaceuticals InBond04280AAC4 | 0.06% | — | — | — | New |
| 0.05% | $9.11 | −25.3% | $6.80 | New | |
| 0.05% | $1.34 | −59.4% | $0.544 | Added +3.2% | |
| 0.05% | $1.79 | −34.1% | $1.18 | New | |
| 0.05% | $57.86 | −21.2% | $45.60 | No change | |
| 0.05% | $7.41 | −7.9% | $6.82 | New | |
Cyclerion Therapeutics Inc.23255M204 | 0.05% | $3.39 | — | — | New |
Electronic Arts Inc.285512109 | 0.05% | $201.70 | — | — | No change |
Travere Therapeutics Inc.Bond89422GAB3 | 0.05% | — | — | — | New |
Biontech Se-AdrBNTX | 0.05% | $106.19 | −13.3% | $92.06 | Added +6.0% |
| 0.05% | $22.00 | −11.0% | $19.58 | New | |
| 0.04% | $14.20 | +15.3% | $16.37 | Reduced −9.8% | |
| 0.04% | $17.89 | −48.8% | $9.15 | Reduced −93% | |
| 0.04% | $44.24 | −42.0% | $25.67 | New | |
Wave Life Sciences Ltd.Y95308105 | 0.04% | $6.21 | — | — | Added +256% |
| 0.04% | $7.15 | −9.1% | $6.51 | New | |
| 0.04% | $10.58 | +4.4% | $11.04 | New | |
| 0.04% | $12.18 | −27.6% | $8.82 | New | |
Nuvalent Inc.670703107 | 0.04% | $76.68 | — | — | No change |
| 0.04% | $3.65 | −26.0% | $2.70 | Added +417% | |
| 0.04% | $36.27 | −18.0% | $29.73 | Added +14% | |
| 0.04% | $1.18 | — | — | No change | |
| 0.04% | $14.05 | −41.2% | $8.26 | No change | |
| 0.04% | $2.28 | −11.8% | $2.01 | Added +64% | |
| 0.04% | $24.19 | +49.1% | $36.06 | No change | |
Si-Bone Inc.SIBN | 0.03% | $14.67 | +28.6% | $18.86 | Added +258% |
| 0.03% | $48.75 | +15.3% | $56.21 | Added +150% | |
Evolus Inc.EOLS | 0.03% | $6.00 | +29.9% | $7.80 | Added +79% |
Ibio Inc.IBIO | 0.03% | $1.46 | −37.0% | $0.92 | Reduced −20% |
| 0.03% | $23.71 | −31.2% | $16.32 | Reduced −38% | |
Geron Corp.GERN | 0.03% | $2.11 | −42.1% | $1.22 | Added +153% |
| 0.03% | $315.13 | −12.1% | $276.97 | New | |
| 0.03% | $3.80 | +250% | $13.31 | New | |
Macrogenics Inc.MGNX | 0.03% | $3.27 | +8.4% | $3.55 | Added +225% |
| 0.03% | $121.53 | +21.0% | $147.10 | Reduced −27% | |
Natera Inc.NTRA | 0.03% | $208.59 | +87.3% | $390.79 | No change |
| 0.03% | $17.59 | +1.8% | $17.91 | New | |
| 0.03% | $22.54 | +1.3% | $22.82 | Added +2.5% | |
Cybin Inc.23256X407 | 0.03% | $7.09 | — | — | Added +160% |
| 0.03% | $11.74 | −25.5% | $8.75 | Added +129% | |
Polypid Ltd.PYPD | 0.02% | $3.71 | +31.9% | $4.90 | No change |
Pulmonx Corp.LUNG | 0.02% | $2.87 | −36.9% | $1.81 | Added +8.0% |
| 0.02% | $16.56 | −36.1% | $10.58 | Reduced −94% | |
| 0.02% | $10.16 | +4.0% | $10.57 | No change | |
| 0.02% | $1.20 | −60.0% | $0.48 | Added +288% | |
| 0.02% | $50.37 | +0.1% | $50.43 | No change | |
| 0.02% | $18.37 | +23.8% | $22.75 | Added +12% | |
| 0.02% | $363.50 | +31.2% | $476.91 | No change | |
Arvinas Inc.ARVN | 0.02% | $7.02 | +7.0% | $7.51 | No change |
| 0.02% | $17.48 | +24.5% | $21.76 | Added +26% | |
| 0.02% | $34.99 | −14.0% | $30.08 | New | |
| 0.02% | $11.48 | −37.9% | $7.13 | No change | |
| 0.02% | $94.07 | −13.5% | $81.35 | Reduced −37% | |
| 0.02% | $4.54 | −44.3% | $2.53 | No change | |
| 0.02% | $7.26 | +44.9% | $10.52 | No change | |
| 0.02% | $1.01 | −70.4% | $0.299 | Added +114% | |
| 0.02% | $103.14 | −2.9% | $100.17 | New | |
| 0.02% | $6.39 | −60.9% | $2.50 | No change | |
| 0.02% | $9.29 | +85.8% | $17.26 | No change | |
| 0.02% | $81.27 | +75.2% | $142.38 | No change | |
| 0.02% | $1.78 | −73.0% | $0.48 | Added +534% | |
| 0.02% | $116.24 | −11.7% | $102.60 | New | |
| 0.02% | $3.61 | +99.1% | $7.19 | Added +13% | |
| 0.02% | $131.03 | −19.3% | $105.70 | No change | |
| 0.02% | $33.71 | −55.6% | $14.96 | Reduced −63% | |
| 0.02% | $4.78 | +11.9% | $5.35 | New | |
| 0.02% | $12.74 | +10.8% | $14.12 | Reduced −64% | |
| 0.02% | $89.02 | −52.8% | $42.04 | Reduced −25% | |
| 0.01% | $2.99 | −12.9% | $2.60 | New | |
Verastem Inc.VSTM | 0.01% | $6.08 | +33.3% | $8.11 | Added +6.6% |
| 0.01% | $4.09 | +14.3% | $4.68 | Added +324% | |
| 0.01% | $5.71 | +4.2% | $5.95 | New | |
| 0.01% | $10.74 | −2.5% | $10.47 | No change | |
| 0.01% | $1.45 | +2.8% | $1.49 | Reduced −13% | |
| 0.01% | $3.90 | −74.8% | $0.983 | Reduced −12% | |
| 0.01% | $32.56 | −17.3% | $26.91 | No change | |
Rezolute Inc.RZLT | 0.01% | $3.29 | +41.1% | $4.64 | Reduced −17% |
Anaptysbio Inc.ANAB | 0.01% | $53.80 | −14.1% | $46.21 | No change |
Neurogene Inc.NGNE | 0.01% | $27.53 | −3.7% | $26.50 | New |
| 0.01% | $50.77 | +0.7% | $51.10 | New | |
Rxsight Inc.RXST | 0.01% | $8.75 | −44.6% | $4.85 | Added +16% |
| 0.01% | $4.68 | +6.7% | $4.99 | No change | |
| 0.01% | $5.71 | −33.3% | $3.81 | Reduced −29% | |
| 0.01% | $10.13 | +1.5% | $10.28 | No change | |
Scynexis Inc.SCYX | 0.01% | $6.21 | −32.0% | $4.22 | New |
Personalis Inc.PSNL | 0.01% | $8.44 | +90.2% | $16.06 | Reduced −40% |
| 0.01% | $4.06 | — | — | No change | |
| 0.01% | $3.29 | −40.7% | $1.95 | New | |
| 0.01% | $5.51 | −28.3% | $3.95 | Added +17% | |
| 0.01% | $10.33 | +33.1% | $13.75 | No change | |
| 0.01% | $2.15 | −66.9% | $0.712 | No change | |
| 0.01% | $3.88 | −13.7% | $3.35 | No change | |
Neuronetics Inc.STIM | 0.01% | $1.58 | +35.0% | $2.14 | No change |
| 0.01% | $2.65 | −47.6% | $1.39 | No change | |
| 0.01% | $6.52 | −63.6% | $2.37 | No change | |
| 0.01% | $11.46 | −51.7% | $5.53 | Reduced −49% | |
Veru Inc.VERU | 0.01% | $2.98 | −18.7% | $2.42 | No change |
| 0.00% | $10.09 | −0.6% | $10.03 | New | |
Clene Inc.CLNN | 0.00% | $6.23 | −37.7% | $3.88 | New |
| 0.00% | $1.00 | −75.1% | $0.25 | Reduced −53% | |
Longeveron Inc.54303L203 | 0.00% | $1.04 | — | — | Reduced −46% |
| 0.00% | $1.40 | −2.2% | $1.37 | No change | |
| 0.00% | $4.12 | −70.4% | $1.22 | No change | |
| 0.00% | $2.01 | −72.1% | $0.56 | No change | |
Ardelyx Inc.ARDX | 0.00% | $6.62 | −50.6% | $3.27 | Reduced −54% |
| 0.00% | $0.7655 | — | — | Reduced −26% | |
Atyr Pharma Inc.ATYR | 0.00% | $0.7214 | −64.7% | $0.255 | No change |
| 0.00% | $0.1386 | −45.8% | $0.0751 | No change | |
| 0.00% | $2.65 | −40.8% | $1.57 | No change | |
| 0.00% | $0.1656 | −39.6% | $0.10 | New | |
| 0.00% | $0.8638 | +23.9% | $1.07 | No change |
Daniel Schneeberger's options
As of Q2 2026. Value = shares the options cover.
| Company | Type | Value of shares covered | Last quarter |
|---|---|---|---|
| Put · bet on a fall or hedge | $18.8M | Added +127% | |
| Put · bet on a fall or hedge | $18.7M | New | |
| Put · bet on a fall or hedge | $10.7M | Added +349% | |
Abivax Sa-AdrABVX | Call · bet on a rise | $5.9M | Added +0.9% |
| Call · bet on a rise | $930K | No change | |
| Put · bet on a fall or hedge | $720.2K | New | |
| Call · bet on a rise | $667.8K | No change | |
| Call · bet on a rise | $623.2K | No change | |
| Call · bet on a rise | $562.8K | Added +71% | |
| Call · bet on a rise | $125.4K | No change | |
Cortexyme Inc.22053A107 | Put · bet on a fall or hedge | — | Sold out |
| Call · bet on a rise | — | Sold out | |
| Call · bet on a rise | — | Sold out | |
Liquidia Corp.LQDA | Put · bet on a fall or hedge | — | Sold out |
| Call · bet on a rise | — | Sold out | |
| Call · bet on a rise | — | Sold out | |
Terns Pharmaceuticals Inc.880881107 | Call · bet on a rise | — | Sold out |
Uniqure NVQURE | Call · bet on a rise | — | Sold out |
Daniel Schneeberger's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
Avidity Biosciences Inc.05370A108 | Sold out | −546,534 | — |
| Added +3491% | +1,819,339 | $35.9M | |
| New | +1,446,375 | $34.5M | |
Crinetics Pharmaceuticals In22663K107 | Added +268% | +829,963 | $41.4M |
Terns Pharmaceuticals Inc.880881107 | Added +69% | +373,084 | $48.2M |
| New | +2,744,714 | $24.6M | |
Abivax Sa-AdrABVX | Added +5.8% | +76,690 | $155.2M |
| New | +1,012,866 | $21.2M | |
| Added +2601% | +390,197 | $20.9M | |
| Sold out | −509,679 | — | |
| Added +485% | +337,684 | $20M | |
| Reduced −4.2% | −143,056 | $91M | |
| Added +894% | +304,272 | $17.1M | |
| Added +206% | +2,550,355 | $21M | |
| Sold out | −59,677 | — | |
| Reduced −90% | −1,123,189 | $1M | |
| Reduced −5.2% | −55,049 | $104.8M | |
| Added +312% | +160,101 | $18.4M | |
| Added +998% | +299,540 | $12.9M | |
| Added +682% | +457,364 | $13.1M | |
Sanofi-AdrSNY | Added +399% | +253,465 | $15.3M |
| Added +39% | +21,256 | $49.4M | |
| Reduced −42% | −2,281,934 | $14.1M | |
Terns Pharmaceuticals Inc.Call880881107 | New | +200,000 | $10.5M |
| New | +1,000,000 | $10.3M | |
| Reduced −56% | −119,122 | $7M | |
| Added +124% | +89,221 | $11.6M | |
| New | +457,137 | $8.5M | |
| Added +4523% | +1,809,004 | $8.4M | |
| New | +374,909 | $7.6M | |
| Added +17% | +92,390 | $41.7M | |
| Reduced −74% | −59,441 | $2.5M | |
Damora Therapeutics Inc.36322Q206 | New | +279,000 | $7.2M |
| Added +140% | +1,420,783 | $10.1M | |
| New | +1,973,282 | $6.9M | |
| Added +268% | +991,967 | $10.9M | |
| Added +760% | +201,223 | $7.4M | |
| Reduced −92% | −555,727 | $923.5K | |
| Sold out | −578,359 | — | |
Korro Bio Inc.KRRO | New | +540,054 | $6.1M |
Septerna Inc.SEPN | Reduced −5.9% | −67,793 | $26.2M |
| Reduced −72% | −129,437 | $1.5M | |
Insmed Inc.INSM | New | +35,392 | $5.8M |
| Reduced −18% | −1,457,377 | $11.1M | |
| Added +5.3% | +74,189 | $8.4M | |
| Added +808% | +233,192 | $5.7M | |
Bridgebio Pharma Inc.Bond10806XAD4 | New | +45,000 | $4.9M |
| New | +495,000 | $4.9M | |
Abivax Sa-AdrCallABVX | New | +44,000 | $4.9M |
Bridgebio Pharma Inc.Bond10806XAJ1 | New | +30,000 | $4.9M |
Zai Lab Ltd-AdrZLAB | Added +14% | +178,847 | $26.8M |
Invivyd Inc.IVVD | Reduced −2.0% | −76,970 | $5M |
| New | +5,060 | $4.7M | |
| New | +55,000 | $4.6M | |
Leonabio Inc.LONA | Added +85% | +333,780 | $7.5M |
Uniqure NVQURE | Reduced −68% | −158,949 | $1.2M |
Aa Mission Acquisition Cor-ACallAAM | Sold out | −405,089 | — |
| Added +215% | +270,084 | $7.1M | |
| Added +12% | +24,930 | $13.3M | |
| Reduced −34% | −218,951 | $13.6M | |
Ataibeckley Inc.N0731H103 | Sold out | −913,242 | — |
Bridgebio Pharma Inc.Bond10806XAB8 | New | +20,000 | $3.6M |
| Added +294% | +227,224 | $6M | |
Immunovant Inc.IMVT | Added +8.0% | +198,042 | $66.5M |
| New | +11,701 | $3.5M | |
| New | +141,814 | $3.3M | |
| Sold out | −150,532 | — | |
Ataibeckley Inc.04650F101 | New | +913,242 | $3.2M |
| Added +142% | +1,265,151 | $5.1M | |
| Added +3402% | +2,511,307 | $3.3M | |
| Added +12% | +110,248 | $13.9M | |
| Added +6.0% | +259,113 | $10.1M | |
| Added +1364% | +421,052 | $3.1M | |
| Sold out | −12,070 | — | |
Liquidia Corp.PutLQDA | Added +308% | +75,500 | $3.8M |
Isoray Inc.CATX | Added +687% | +654,142 | $3.1M |
| Sold out | −226,248 | — | |
| New | +90,593 | $2.8M | |
| Added +235% | +149,789 | $3.4M | |
| Sold out | −170,000 | — | |
Pepgen Inc.PEPG | Added +4264% | +1,570,796 | $2.8M |
Apellis Pharmaceuticals03753U106 | Added +263% | +52,500 | $2.9M |
| Reduced −81% | −377,974 | $1.3M | |
Astria Therapeutics Inc.04635X102 | Sold out | −173,557 | — |
Biogen Inc.BIIB | Reduced −55% | −13,300 | $2M |
| Sold out | −641,988 | — | |
| Added +869% | +30,400 | $2.5M | |
| Reduced −33% | −12,959 | $4.3M | |
| Sold out | −81,399 | — | |
| New | +742,400 | $1.9M | |
| New | +15,000 | $1.9M | |
CG Oncology Inc.CGON | Reduced −28% | −72,440 | $12.6M |
Engene Holdings Inc.29286M105 | Reduced −56% | −170,000 | $910.4K |
Cybin Inc.23256X407 | Reduced −87% | −207,112 | $150.1K |
| Reduced −18% | −772,579 | $16M | |
Regenxbio Inc.RGNX | Reduced −69% | −100,432 | $372.2K |
Aquestive Therapeutics Inc.PutAQST | Sold out | −254,000 | — |
Climb Bio Inc.CLYM | Reduced −58% | −834,813 | $4.1M |
Arcellx Inc.03940C100 | Added +1.9% | +600 | $3.7M |
Amicus Therapeutics Inc.03152W109 | New | +105,000 | $1.5M |
| New | +5,501 | $1.5M | |
| Reduced −7.7% | −11,186 | $13M | |
| Added +8.5% | +123,679 | $15.4M | |
Gossamer Bio Inc.PutGOSS | Sold out | −463,200 | — |
| Reduced −78% | −481,560 | $496.6K | |
| New | +15,000 | $1.3M | |
Omeros Corp.PutOMER | Sold out | −75,000 | — |
| New | +222,555 | $1.3M | |
| Reduced −34% | −1,881,419 | $7.5M | |
| Added +1.0% | +600 | $3.8M | |
| New | +33,000 | $1.2M | |
| New | +95,350 | $1.2M | |
| New | +750,000 | $1.2M | |
| Reduced −17% | −196,287 | $4.9M | |
Schrodinger Inc.SDGR | New | +101,500 | $1.2M |
Karyopharm Therapeutics Inc.CallKPTI | New | +205,200 | $1.1M |
Day One Biopharmaceuticals I23954D109 | New | +49,923 | $1.1M |
Arrowhead Pharmaceuticals In04280AAC4 | New | +10,000 | $1M |
Infleqtion Inc.INFQ | Sold out | −64,887 | — |
Urogen Pharma Ltd.CallURGN | Sold out | −40,000 | — |
| Sold out | −1,900 | — | |
Uniqure NVCallQURE | Added +233% | +70,000 | $1.6M |
| Sold out | −41,065 | — | |
| Added +1.1% | +600 | $792.8K | |
| Sold out | −58,230 | — | |
Astrazeneca Plc-Spons ADR046353108 | Sold out | −9,000 | — |
| New | +117,909 | $815.9K | |
Zura Bio Ltd.ZURA | Added +12% | +68,338 | $3.8M |
| Added +13% | +30,370 | $14.5M | |
| Reduced −63% | −5,000 | $567.2K | |
| Added +16% | +45,000 | $3.1M | |
| New | +57,688 | $771K | |
| New | +8,750 | $770K | |
| Added +628% | +148,514 | $907.3K | |
| Added +22% | +53,094 | $4.1M | |
| Added +14% | +18,455 | $4.2M | |
| Added +13% | +260,000 | $4M | |
Ventyx Biosciences Inc.92332V107 | Sold out | −81,600 | — |
Fulcrum Therapeutics Inc.CallFULC | Sold out | −65,000 | — |
| Added +14% | +32,420 | $8.1M | |
Adicet Bio Inc.ACET | Reduced −58% | −74,819 | $366.6K |
| Added +416% | +78,467 | $1.1M | |
| Added +133% | +60,000 | $999.6K | |
| Added +194% | +51,606 | $1.3M | |
| Reduced −67% | −6,500 | $377.7K | |
Neurogene Inc.NGNE | Sold out | −30,633 | — |
Pharvaris NVPHVS | Added +23% | +20,000 | $3M |
| Reduced −0.4% | −400 | $2.9M | |
| New | +6,200 | $572.8K | |
| Added +35% | +75,000 | $94.5K | |
| Added +21% | +12,100 | $4.4M | |
| Reduced −20% | −535,448 | $12.1M | |
Alector Inc.ALEC | Reduced −5.2% | −58,000 | $2.3M |
| New | +152,825 | $522.7K | |
Replimune Group Inc.CallREPL | Added +300% | +75,000 | $765K |
| Added +9.9% | +1,359 | $6.7M | |
| Reduced −22% | −16,000 | $869.1K | |
Vaxcyte Inc.PCVX | Reduced −18% | −56,505 | $15.1M |
Vyne Therapeutics Inc.92941V308 | Added +319% | +810,108 | $635.7K |
Savara Inc.SVRA | Added +4.2% | +59,083 | $8M |
Novo-Nordisk A/S-Spons ADRCallNVO | New | +13,000 | $477.8K |
Freenome Inc.FRNM | Added +9.4% | +42,861 | $5.5M |
| Reduced −72% | −132,944 | $237.4K | |
Novocure Ltd.NVCR | Sold out | −34,000 | — |
Omeros Corp.OMER | Sold out | −25,000 | — |
Cytomx Therapeutics Inc.CallCTMX | Sold out | −100,000 | — |
| Reduced −0.8% | −2,300 | $3.6M | |
| Added +19% | +483,620 | $13.3M | |
| Added +9.0% | +13,208 | $12M | |
| Added +173% | +86,736 | $761.6K | |
| New | +30,500 | $384.9K | |
Verastem Inc.VSTM | New | +71,100 | $376.8K |
Moonlake ImmunotherapeuticsCallMLTX | New | +20,000 | $372.8K |
| Added +25% | +42,051 | $12.1M | |
Pfizer Inc.PFE | Added +6.9% | +5,000 | $2.2M |
Soleno Therapeutics Inc.834203309 | Added +12% | +5,000 | $1.6M |
| New | +20,000 | $361.8K | |
| Reduced −25% | −47,328 | $4.8M | |
| Sold out | −22,000 | — | |
Surrozen Inc.SRZN | New | +12,000 | $349.6K |
| Reduced −61% | −35,000 | $193.6K | |
Dayforce Inc.15677J108 | Sold out | −5,000 | — |
| New | +71,298 | $330.8K | |
| New | +2,500 | $329.4K | |
Corbus Pharmaceuticals HoldiCallCRBP | New | +35,000 | $328.7K |
Wave Life Sciences Ltd.Y95308105 | New | +44,900 | $325.5K |
Ascendis Pharma A/S04351P101 | Reduced −1.2% | −300 | $5.7M |
| New | +8,000 | $322.5K | |
| New | +35,000 | $315K | |
Pulmonx Corp.LUNG | Added +5.4% | +19,087 | $483.1K |
| New | +13,400 | $280.7K | |
| Sold out | −400 | — | |
Xencor Inc.XNCR | Added +67% | +37,500 | $1.1M |
| Added +79% | +810 | $843.6K | |
| Sold out | −113,839 | — | |
Cortexyme Inc.Put22053A107 | Reduced −38% | −30,000 | $5.1K |
| Added +41% | +5,300 | $1M | |
| New | +1,600 | $256.5K | |
| Added +66% | +50,910 | $443.3K | |
| Reduced −47% | −847,391 | $3M | |
| New | +19,517 | $250.2K | |
| New | +640 | $249.9K | |
Rubrik Inc.RBRK | New | +4,900 | $240K |
| New | +5,000 | $239.9K | |
| Added +81% | +64,636 | $338.4K | |
| Reduced −57% | −17,006 | $401.9K | |
| Added +43% | +3,000 | $923.7K | |
Longeveron Inc.54303L203 | New | +200,000 | $208K |
Anaptysbio Inc.ANAB | New | +3,698 | $205.1K |
| New | +20,000 | $202K | |
Dyne Therapeutics Inc.CallDYN | Sold out | −10,000 | — |
| Reduced −64% | −90,021 | $1M | |
Omniab Inc.OABI | Added +0.4% | +3,000 | $1.1M |
| Reduced −71% | −25,000 | $59.9K | |
Ultragenyx Pharmaceutical InCallRARE | Added +100% | +10,000 | $419K |
| New | +43,500 | $186.6K | |
| New | +17,500 | $186.4K | |
Lipocine Inc.LPCN | New | +23,180 | $185.2K |
Rallybio Corp.RLYB | New | +20,535 | $184.2K |
| Added +4.0% | +45,833 | $1.4M | |
Avantor Inc.AVTR | Added +14% | +10,000 | $627.2K |
| New | +50,000 | $172.5K | |
| Reduced −80% | −40,000 | $91.1K | |
Erasca Inc.ERAS | New | +10,000 | $161.8K |
| New | +40,900 | $161.1K | |
| Added +129% | +130,000 | $286.5K | |
Personalis Inc.PSNL | New | +25,000 | $159.3K |
Si-Bone Inc.SIBN | New | +12,580 | $158.9K |
Q32 Bio Inc.QTTB | Added +75% | +15,000 | $224.7K |
Outlook Therapeutics Inc.PutOTLK | Sold out | −100,000 | — |
| Added +46% | +5,500 | $408.8K | |
| New | +50,000 | $153.5K | |
| Added +100% | +5,000 | $627.5K | |
Geron Corp.GERN | Reduced −41% | −136,176 | $298K |
Neuronetics Inc.STIM | New | +100,000 | $145K |
Ardelyx Inc.ARDX | New | +23,900 | $143.2K |
Alkermes PLCALKS | Reduced −27% | −17,300 | $1.6M |
Inflarx NVIFRX | New | +158,271 | $141.6K |
Cortexyme Inc.22053A107 | Added +17% | +7,188 | $5.1K |
| Sold out | −521,980 | — | |
Inovio PharmaceuticalsCallINO | Sold out | −75,500 | — |
Kezar Life Sciences Inc.49372L209 | Reduced −30% | −35,507 | $607.9K |
Generation Bio Co.37148K209 | Sold out | −22,144 | — |
| Reduced −9.1% | −43,300 | $1.5M | |
| Added +1.0% | +200 | $553.5K | |
| New | +15,000 | $115.8K | |
Macrogenics Inc.MGNX | New | +40,000 | $115.6K |
| New | +43,000 | $113.1K | |
| Reduced −6.3% | −1,815 | $1.3M | |
Ibio Inc.IBIO | Added +16% | +64,347 | $892.8K |
Gossamer Bio Inc.CallGOSS | Sold out | −35,100 | — |
| Reduced −0.2% | −333 | $282K | |
| Added +20% | +3,200 | $905.2K | |
| New | +10,000 | $106.4K | |
| Added +8.8% | +1,300 | $645K | |
| Sold out | −26,344 | — | |
| Added +0.9% | +103 | $9.4M | |
Rezolute Inc.RZLT | Added +52% | +20,000 | $179K |
| Reduced −0.1% | −100 | $119K | |
Vistagen Therapeutics Inc.PutVTGN | Sold out | −120,000 | — |
Arvinas Inc.ARVN | Reduced −0.9% | −500 | $610.5K |
Bioatla Inc.09077B104 | Added +25% | +45,000 | $36.7K |
| Reduced −4.7% | −315 | $885.1K | |
Annexon Inc.ANNX | Added +15% | +7,000 | $304.7K |
Esperion Therapeutics29664W105 | New | +21,400 | $58.6K |
| Reduced −0.3% | −100 | $1.5M | |
| New | +13,861 | $47.4K | |
| Added +28% | +341,665 | $12.1M | |
| Reduced −17% | −8,300 | $70.4K | |
| Reduced −4.8% | −1,000 | $281K | |
| New | +10,000 | $41.5K | |
Rxsight Inc.RXST | Added +98% | +21,447 | $266.4K |
| Added +0.2% | +2,500 | $1M | |
| Reduced −35% | −17,500 | $64.5K | |
| Reduced −1.0% | −14,900 | $2.6M | |
| Added +11% | +4,789 | $860.5K | |
Nuvalent Inc.670703107 | Added +1.5% | +100 | $711.2K |
Invo Fertility Inc.44984F807 | Sold out | −26,722 | — |
| Reduced −13% | −2,500 | $1.1M | |
| Added +20% | +127,566 | $429.3K | |
Io Biotech Inc.IOBTQ | Sold out | −24,964 | — |
Evolus Inc.EOLS | Added +56% | +20,000 | $229.6K |
Biohaven Ltd.BHVN | Added +31% | +10,500 | $378.8K |
| Added +21% | +5,332 | $5.9M | |
| Added +24% | +10,000 | $648.6K | |
Immunic Inc.4525EP101 | New | +30,000 | $0 |
Daniel Schneeberger's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Health Care | 87% |
| Other | 11% |
| Financials | 2.1% |
| Technology | 0.3% |
| Industrials | 0.2% |
| Real Estate | 0.1% |
| Consumer Discretionary | 0.0% |
Portfolio performance: Daniel Schneeberger vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | +98.6% | +29.6% |
| S&P 500 | +60.3% | +19.5% |
| Nasdaq-100 | +75.1% | +23.6% |
Prices were available for 87% of the portfolio value on average; the rest is left out of the return.
Daniel Schneeberger's most traded stocks
Quarters with a buy or a sell, all reports since Q4 2023.
| Company | Quarters bought | Quarters sold |
|---|---|---|
| 8 | 4 | |
| 6 | 4 | |
| 6 | 4 | |
| 7 | 3 | |
Vaxcyte Inc.PCVX | 6 | 4 |
Regenxbio Inc.RGNX | 4 | 6 |
Abivax Sa-AdrABVX | 8 | 2 |
Alkermes PLCALKS | 5 | 5 |
| 8 | 2 | |
Biohaven Ltd.BHVN | 7 | 3 |
Sanofi-AdrSNY | 6 | 4 |
| 5 | 5 | |
Pfizer Inc.PFE | 6 | 4 |
| 5 | 5 | |
Savara Inc.SVRA | 7 | 3 |